Page 67 - ஒருங்கிணைந்த பாதுகாப்பு ஊழியர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒருங்கிணைந்த பாதுகாப்பு ஊழியர்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒருங்கிணைந்த பாதுகாப்பு ஊழியர்கள் Today - Breaking & Trending Today

Welcome To IANS Live - NATION - Ambitious initiative towards a drug-free India


Photo Credit: IANS
IANSLive
Every year, the birth anniversary of Mahatma Gandhi is observed as National Anti-Drug Addiction Day to honour his commitment towards eradicating the menace of drug and substance abuse. Prime Minister Narendra Modi has also time and again highlighted the perils of substance abuse and stated that it is a dangerous disease which traps a person into a never-ending vicious cycle. Unfortunately, this menace is on the rise as is evident from the findings of National Survey on Extent and Pattern of Substance Use.
To get full access of the story, click here to subscribe to IANS News Service ....

Mahatma Gandhi , Narendra Modi , National Anti , News Service , India Private , National Survey On Extent , National Anti Drug Addiction Day , Minister Narendra Modi , National Survey , All Rights , மகாத்மா காந்தி , நரேந்திர மோடி , தேசிய எதிர்ப்பு , செய்தி சேவை , இந்தியா ப்ரைவேட் , தேசிய கணக்கெடுப்பு ஆன் அளவு , தேசிய எதிர்ப்பு மருந்து நாள் , அமைச்சர் நரேந்திர மோடி , தேசிய கணக்கெடுப்பு , அனைத்தும் உரிமைகள் ,

Oncolytics Biotech Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors


Oncolytics Biotech Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors
42% (3/7)
These very exciting data demonstrate pelareorep s ability to overcome major shortcomings of CAR T cells, said Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics Biotech Inc. Despite commercial success in
hematological cancers, CAR T therapies have limited efficacy against solid tumors due to immunosuppressive tumor microenvironments (TMEs) that promote T cell exhaustion and exclusion. Pelareorep s ability to reverse immunosuppressive TMEs has been well documented in the clinic, and combining CAR T cells with pelareorep may enable their success against ....

Matt Coffey , Timothy Mccarthy , Oncolytics Biotech Inc , National Cancer Institute , Company Contact , Securities Exchange , Global Head Of Business Development , Duke University , Mayo Clinic , Chief Executive Officer , Oncolytics Biotech , Global Head , Business Development , Oncolytic Viruses , Engineering Patient Immune Cells , Treat Their , Updated July , Securities Exchange Act , மேட் காஃபி , தீமோத்தேயு ம்க்கார்தீ , தேசிய புற்றுநோய் நிறுவனம் , நிறுவனம் தொடர்பு , பத்திரங்கள் பரிமாற்றம் , உலகளாவிய தலை ஆஃப் வணிக வளர்ச்சி , டியூக் பல்கலைக்கழகம் , மயோ சிகிச்சையகம் ,

Dr Reddys Lab launches lansoprazole tablets in US


The drug major on Monday announced the launch of lansoprazole DR orally disintegrating tablets in the US market.Dr. Reddy s Laboratories lansoprazole DR orally disintegrating tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100. The product is therapeutic equivalent generic version of Prevacid SoluTab delayed release orally disintegrating tablets approved by the U.S. Food and Drug Administration (USFDA). Prevacid is a trademark of Takeda Pharmaceuticals U.S.A., Inc.
Lansoprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). According to IMS Health, the Prevacid brand and generic had US sales of approximately $87 million for the most recent twelve months ending in December 2020. ....

Reddy Laboratorie , Prevacid Solutab , Services Active Ingredients , Takeda Pharmaceuticals United Statesa Inc , Drug Administration , Takeda Pharmaceuticals United Statesa , Pharmaceutical Services , Active Ingredient , Global Generics , Capital Market , Chemical Compounds , Health Care , Proton Pump Inhibitors , Dr Reddys Laboratories , Nifty 50 , Orally Disintegrating Tablet , Generic Drug , United States , Kims Health , சிவப்பு ஆய்வக , சேவைகள் செயலில் பொருட்கள் , மருந்து சேவைகள் , செயலில் மூலப்பொருள் , உலகளாவிய ஜெநெரிக்ஸ் , மூலதனம் சந்தை , இரசாயன கலவைகள் ,